DOSAGE FORMS – Pharma.Tips

Injectable Quality Failures Like Particulates? Sterile Manufacturing Solutions That Work

Quality inspectors and manufacturing teams must be vigilant for signs of contamination and other quality indicators that can arise during the production of injectable products. Common symptoms of quality failures…

Cream Separation and Ointment Grittiness? Root Causes and Fixes for Topicals

Identifying the symptoms of cream separation and ointment grittiness can often be the first step in understanding the issues at hand. Signals that indicate problems may include:Click to read the…

Inhaler Dose Delivery Problems? Device-Formulation Solutions for Consistent Performance

Identifying anomalies in the performance of inhalation and nasal dosage forms is the first step toward resolution. Symptoms may manifest during routine checks or through customer feedback. Key indicators include:Click…

Suppository Melting and Leakage Issues? Formulation and Packaging Solutions

Recognizing the symptoms of melting and leakage in rectal and vaginal dosage forms is often the first step toward resolution. Common indicators may include:Click to read the full article.

Dental Product Performance Problems? Fixes for Consistency, Stability, and Release

Performance problems in dental dosage forms may display a range of symptoms that signal the need for immediate investigation. These symptoms can manifest either on the manufacturing floor or within…

Emulsion Inversion after excipient change: mixing and sampling controls for QA review

Detecting emulsion inversion often begins with visual or instrumental signals observed during the production process, stability testing, or post-manufacturing evaluations.Click to read the full article.

Color Change in cream manufacturing: GMP investigation and CAPA strategy

Recognizing the initial symptoms or signals of a color change during cream manufacturing is the first step in addressing potential quality issues. Symptoms can vary from batch to batch, but…

Texture Variability in ointment filling: mixing and sampling controls for QA review

Identifying texture variability begins with observing specific symptoms in the production environment. Symptoms may manifest in various ways:Click to read the full article.

Bioburden Spike Pre-Filtration during hold-time study: CAPA package with evidence and effectiveness checks

Symptoms of potential bioburden spikes may manifest as elevated levels of microbial contamination observed during routine quality control checks or during hold-time studies. Signals that should prompt immediate attention include:Click…

Sterility Test Failure during aseptic filling: data integrity checks for lab and shop floor

Before diving into root causes of sterility test failures, it's important to recognize the various signals that can indicate a potential issue:Click to read the full article.

Air Entrapment during inspection preparation: GMP investigation and CAPA strategy

In a manufacturing environment, recognizing the symptoms and signals of air entrapment is critical for prompt intervention. Some of the most common signals include:Click to read the full article.

Unplanned Line Stoppage post-sterile filtration: facility, people, process root cause mapping

The first step in addressing an unplanned line stoppage is to identify symptoms or signals that can indicate underlying issues. Examples may include:Click to read the full article.